Condition: Macular Degeneration · Age-Related Macular Degeneration · Choroidal Neovascularization · Sponsor: EyeBiotech Ltd.
Researchers are looking for new ways to treat neovascular age-related macular degeneration (NVAMD). Available standard (usual) treatments for NVAMD, such as aflibercept, may not work for every person. Researchers want to learn if a trial medicine called tiespectus (also called MK-8748 or EYE201) can treat NVAMD. The goal of this trial is to learn if tiespectus works as well as aflibercept to treat NVAMD.
This description comes directly from the study's public registry record.
Toll Free Number · 1-888-577-8839 · Trialsites@msd.com
Always discuss trial participation with your own doctor first.
| Associated Retina Consultants - Gilbert | Gilbert, Arizona, United States | Recruiting |
| The Retina Partners | Encino, California, United States | Recruiting |
| Northern California Retina Vitreous Associates Medical Group, Inc. | Mountain View, California, United States | Recruiting |
| Retina Consultants of Southern Colorado | Colorado Springs, Colorado, United States | Recruiting |
| RSC Research LLC | Denver, Colorado, United States | Recruiting |
| Retina Consultants of Southern Colorado | Pueblo, Colorado, United States | Recruiting |
| Connecticut Eye Consultants, P.C. | Danbury, Connecticut, United States | Recruiting |
| Retina Consultants, P.C. | Manchester, Connecticut, United States | Recruiting |
| Retina Group of New England | Waterford, Connecticut, United States | Recruiting |
| Retina Group of Florida | Fort Myers, Florida, United States | Recruiting |
| Florida Retina Institute | Orlando, Florida, United States | Recruiting |
| Retina Group of Florida (Site 065) | Sarasota, Florida, United States | Recruiting |
+ 51 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07496567